Chavan, J
GLP-1 receptor agonists have now received FDA approvals for cardiovascular risk reduction, obstructive sleep apnea, and chronic kidney disease, in addition to their original diabetes and obesity indications
Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, Cameron J, Grosse J, Reimann F, and Gribble FM
Insights from Recent Reports News Coverage in 2023 July 2023 saw an influx of reports highlighting the challenges faced by individuals using Ozempic and Wegovy
Is it normal to see tiny air bubbles in the vial after drawing from it
Ketamine stands out among psychedelic and psychedelic-adjacent therapies because it is the only one included in the World Health Organizations Model List of Essential Medicines